A mixture of B. bifidum, B. longum, B. lactis, and B. breve, administered to mice after melanoma implantation concurrent with anti-PD-L1 immunotherapy resulted in a significantly decreased tumor volume and increased number of tumor-infiltrating CD8+ T cells compared to anti-PD-L1 therapy alone (34). Here, CD274 is linked to neoplasm.